EUVIMEDOpdag EUVIMED
Open access

On standardization of controls in lifespan studies

Olga Spiridonova, Dmitrii Kriukov, Nikolai Nemirovich-Danchenko, Leonid Peshkin

Aging · 2024

DOI: 10.18632/aging.205604 ↗

At a glance

Journal article in Aging, 2024. Written by Olga Spiridonova and 3 co-authors. Institution: Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. Major MEDLINE topics: Longevity, Aging. Cited 11 times so far (Crossref); 11 references. The full text is freely available in PubMed Central. Funded by: NIA NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The search for interventions to slow down and even reverse aging is a burgeoning field. The literature cites hundreds of supposedly beneficial pharmacological and genetic interventions in model organisms: mice, rats, flies and worms, where research into physiology is routinely accompanied by lifespan data. However, when experimental animals from one article live as long as controls from another article, comparing the results of interventions across studies can yield misleading outcomes. Theoretically, all lifespan data are ripe for re-analysis: we could contrast the molecular targets and pathways across studies and help focus the further search for interventions. Alas, the results of most longevity studies are difficult to compare. This is in part because there are no clear, universally accepted standards for conducting such experiments or even for reporting such data. The situation is worsened by the fact that the authors often do not describe experimental conditions completely. As a result, works on longevity make up a set of precedents, each of which might be interesting in its own right, yet incoherent and incomparable at least for the reason that in a general context, it may indicate, for example, not prolonging the life of an average organism, but compensating for any genetic abnormalities of a particular sample or inappropriate living conditions. Here we point out specific issues and propose solutions for quality control by checking both inter- and intra-study consistency of lifespan data.

Subjects

MeSH terms (MEDLINE)

LongevityAgingAnimalsMiceRatsReference Standards

Author keywords

aginganimal disease modelsdata standardizationsurvival modeling

Authors and institutions

  • Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.

Funding

  • NIA NIH HHS

Cite

APA

Spiridonova, O., Kriukov, D., Nemirovich-Danchenko, N., & Peshkin, L. (2024). On standardization of controls in lifespan studies. Aging. https://doi.org/10.18632/aging.205604

Vancouver

Spiridonova O, Kriukov D, Nemirovich-Danchenko N, Peshkin L. On standardization of controls in lifespan studies. Aging. 2024. doi:10.18632/aging.205604

BibTeX
@article{Spiridonova2024,
  author = {Spiridonova, Olga and Kriukov, Dmitrii and Nemirovich-Danchenko, Nikolai and Peshkin, Leonid},
  title = {On standardization of controls in lifespan studies},
  journal = {Aging},
  year = {2024},
  doi = {10.18632/aging.205604}
}
Start for free →